Concentration Details

Metabolite
HMDB0012162 (4-Methoxytyramine)
Biospecimen
Blood
Status
Detected and Quantified
Data source
Referenced
Concentration
0.022 +/- 0.015 uM
Age
Adult (>18 years old)
Sex
Not Specified
Condition
Parkinson's disease
Comments
In plasma 3 hours after oral administration of DOPA
References
    1. Ishimitsu T, Hirose S, Asahara K, Imaizumi M: The formation of 3-hydroxy-4-methoxyphenylalanine and 3-hydroxy-4-methoxyphenethylamine in plasma during L-DOPA therapy in patients with Parkinson's disease. Chem Pharm Bull (Tokyo). 1984 Aug;32(8):3320-2. [PubMed:6518609 ]